Zonisamide produces weight loss in psychotropic drug-treated psychiatric outpatients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 8, 2011, Pages 1918-1921

  Lim, JaeHyoung ^a   Ko, Young Hoon ^a   Joe, Sook Haeng ^a   Han, Changsu ^a   Lee, Moon Soo ^a   Yang, Jaewon ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Obesity; Psychotropic drugs; Weight; Zonisamide

Indexed keywords

AMITRIPTYLINE; CLOZAPINE; LITHIUM; MIRTAZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID; ZONISAMIDE;

ADULT; AMNESIA; ARTICLE; BINGE EATING DISORDER; BODY MASS; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIGRAINE; MINOR AFFECTIVE DISORDER; NAUSEA; OBESITY; OUTCOME ASSESSMENT; OUTPATIENT CARE; PARESTHESIA; PRURITUS; REBOUND; SEX DIFFERENCE; SIDE EFFECT; SOMNOLENCE; SWEATING; TREATMENT DURATION; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; FEMALE; HUMANS; ISOXAZOLES; MALE; MENTAL DISORDERS; MIDDLE AGED; OUTPATIENTS; OVERWEIGHT; PSYCHOTROPIC DRUGS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WEIGHT GAIN; WEIGHT LOSS;

EID: 82455212951     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.07.007     Document Type: Article

References (24)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV-TR 2000, Washington, DC. 4th ed.
2. Ashkenazi A., Benlifer A., Korenblit J., Silberstein S.D. Zonisamide for migraine prophylaxis in refractory patients. Cephalalgia 2006, 26:1199-1202.
3. Berigan T.R. Zonisamide treatment of bipolar disorder: a case report. Can J Psychiatry 2002, 47:887.
4. Bray G.A., Greenway F.L. Pharmacological treatment of the overweight patient. Pharmacol Rev 2007, 59:151-184.
5. Drake M.E., Greathouse N.I., Renner J.B., Armentbright A.D. Open-label zonisamide for refractory migraine. Clin Neuropharmacol 2004, 27:278-280.
6. Gadde K.M., Franciscy D.M., Wagner H.R., Krishnan K.R. Zonisamide for weight loss in obese adults: a randomized controlled trial. JAMA. 2003, 289:1820-1825.
7. Ghaemi S.N., Shirzadi A.A., Klugman J., Berv D.A., Pardo T.B., Filkowski M.M. Is adjunctive open-label zonisamide effective for bipolar disorder?. J Affect Disord 2008, 105:311-314.
8. Kothare S.V., Kaleyias J. Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety. Expert Opin Drug Metab Toxicol 2008, 4:493-506.
9. Krusz J.C. Treatment of chronic pain with zonisamide. Pain Pract 2003, 3:317-320.
10. Maayan L., Vakhrusheva J., Correll C.U. Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis. Neuropsychopharmacology 2010, 35:1520-1530.
11. McElroy S.L., Kotwal R., Guerdjikova A.I., Welge J.A., Nelson E.B., Lake K.A., et al. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. J Clin Psychiatry 2006, 67:1897-1906.
12. McElroy S.L., Suppes T., Keck P.E., Black D., Frye M.A., Altshuler L.L., et al. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. J Clin Psychiatry 2005, 66:617-624.
13. Newcomer J.W. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry 2007, 68(Suppl 1):20-27.
14. Padwal R., Li S.K., Lau D.C. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev 2003, CD004094.
15. Pompili M., Serafini G., Del Casale A., Rigucci S., Innamorati M., Girardi P., et al. Improving adherence in mood disorders: the struggle against relapse, recurrence and suicide risk. Expert Rev Neurother 2009, 9:985-1004.
16. Ricca V., Castellini G., Lo Sauro C., Rotella C.M., Faravelli C. Zonisamide combined with cognitive behavioral therapy in binge eating disorder: a one-year follow-up study. Psychiatry (Edgmont) 2009, 6:23-28.
17. Rogawski M.A., Loscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004, 5:553-564.
18. Ruetsch O., Viala A., Bardou H., Martin P., Vacheron M.N. Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management. Encéphale 2005, 31:507-516.
19. Schwartz T.L., Nihalani N., Jindal S., Virk S., Jones N. Psychiatric medication-induced obesity: a review. Obes Rev 2004, 5:115-121.
20. Stahl S.M. Stahl's essential psychopharmacology: the prescriber's guide 2009, Cambridge University Press, Cambridge; New York. 3rd ed.
21. Wang P.W., Yang Y.S., Chandler R.A., Nowakowska C., Alarcon A.M., Culver J., et al. Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: a pilot study. J Psychiatr Res 2008, 42:451-457.
22. Wellmer J., Wellmer S., Bauer J. The impact of zonisamide on weight. A clinical study in 103 patients with epilepsy. Acta Neurol Scand 2009, 119:233-238.
23. Werneke U., Taylor D., Sanders T.A. Options for pharmacological management of obesity in patients treated with atypical antipsychotics. Int Clin Psychopharmacol 2002, 17:145-160.
24. Yang J., Lee M.S., Joe S.H., Jung I.K., Kim S.H. Zonisamide-induced weight loss in schizophrenia: case series. Clin Neuropharmacol 2010, 33:104-106.